New AI-COVID Software Helps Clinical Labs to Rule-Out COVID-19
Image Credit: Gorodenkoff/shutterstock
Artificial intelligence could soon be added to the testing toolkits of hospital-based laboratories and doctors at the forefront of the COVID-19 pandemic.
Recent research by collaborators from the University of Vermont and Cedars-Sinai explains the performance of Biocogniv’s new AI-COVID™ software. The researchers discovered high precision in estimating the probability of COVID-19 infection during routine blood tests, which could enable hospitals to reduce the number of patients referred for scarce PCR testing.
Nine months into this pandemic, we now have a better understanding of how to care for patients with COVID-19, but there’s still a big bottleneck in COVID-19 diagnosis with PCR testing.
Boston
Massachusetts
United-states
Vermont
Tanya-kanigan
Jennifer-joe
Timothy-plante
George-hauser
Artur-adib
Victor-tapson
Software-helps-clinical-labs-to-rule
University-of-vermont
Washington [US], December 11 (ANI): A recent study conducted with collaborators from the University of Vermont and Cedars-Sinai describes the performance of Biocogniv s new AI-COVID software.
The team found high accuracy in predicting the probability of COVID-19 infection using routine blood tests, which can help hospitals reduce the number of patients referred for scarce PCR testing.
Their study in the Journal of Medical Internet Research is available online. Nine months into this pandemic, we now have a better understanding of how to care for patients with COVID-19, said lead author and University of Vermont Assistant Professor Timothy Plante, M.D., M.H.S., but there s still a big bottleneck in COVID-19 diagnosis with PCR testing.
Boston
Massachusetts
United-states
Kerala
India
Washington
Vermont
Tanya-kanigan
Jennifer-joe
George-hauser
Artur-adib
Victor-tapson
AI tool helps clinical labs to rule out COVID-19
Hospital-based laboratories and doctors at the front line of the COVID-19 pandemic might soon add artificial intelligence to their testing toolkit. A recent study conducted with collaborators from the University of Vermont and Cedars-Sinai describes the performance of Biocogniv s new AI-COVID™ software. The team found high accuracy in predicting the probability of COVID-19 infection using routine blood tests, which can help hospitals reduce the number of patients referred for scarce PCR testing.
Their study in the
/
e24048.
Nine months into this pandemic, we now have a better understanding of how to care for patients with COVID-19, but there s still a big bottleneck in COVID-19 diagnosis with PCR testing.
Boston
Massachusetts
United-states
Vermont
Tanya-kanigan
Jennifer-joe
Timothy-plante
George-hauser
Artur-adib
Victor-tapson
Emily-henderson
Journal-of-medical-internet-research
Related Company:
AI software uses routine blood work to assist clinical labs with COVID testing shortage
Vermont Business Magazine Hospital-based laboratories and doctors at the front line of the COVID-19 pandemic might soon add artificial intelligence to their testing toolkit. A recent study conducted with collaborators from the University of Vermont and Cedars-Sinai describes the performance of Biocogniv’s new AI-COVID software. The team found high accuracy in predicting the probability of COVID-19 infection using routine blood tests, which can help hospitals reduce the number of patients referred for scarce PCR testing.
Their study in the
“Nine months into this pandemic, we now have a better understanding of how to care for patients with COVID-19,” says lead author and University of Vermont Assistant Professor Timothy Plante, MD, “but there’s still a big bottleneck in COVID-19 diagnosis with PCR testing.”
Boston
Massachusetts
United-states
South-burlington
Vermont
The-university-of-vermont
Tanya-kanigan
Jennifer-joe
Timothy-plante
George-hauser
Artur-adib
Victor-tapson
vimarsana © 2020. All Rights Reserved.